theMednetRegister

Hematologic Malignancies

Dermatology   

Questions discussed in this category

What treatment approach is best for management of neutrophilic dermatosis in a patient with acute myeloid leukemia? Any suggestions for long term management?
1 Answer available
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
2 Answers available
Have you seen CD30+ lymphoproliferative skin lesions with Upadacitinib treatment of atopic dermatitis?
1 Answer available
How do you approach balancing the potential risk of worsening actinic damage and maintaining CTCL clearance in patients treated with nb-UVB?
2 Answers available
What first-line therapies do you recommend for patients with folliculotropic mycosis fungoides?
Has topical dapsone worked? 
3 Answers available
What is the role of radiotherapy in cutaneous pseudolymphoma?
Are there particular indications you use for RT? i.e. multiply recurrent, refractory to other therapies, near critical structures, unresectable (or re...
1 Answer available
Do you hold histone deacetylase (HDAC) inhibitors for patients receiving palliative radiation therapy for cutaneous lymphomas?
If so, how long before/after radiation?
1 Answer available
How do you differentiate atopic dermatitis from mycosis fungoides histologically?
1 Answer available
How long do you give systemic therapies or skin directed therapies to work before changing treatments in patients with diffuse skin limited mycoses fungoides?
Do you have a preferred sequence of therapies for diffuse skin limited MF?
1 Answer available
What is your escalation strategy for chronic GvHD?
How does belumosudil now fit in your approach to steroid refractory chronic graft-versus-host disease?
1 Answer available
How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available


Papers discussed in this category

JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
Transplant Cell Ther, 2021 Sep 02
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience.

Related Topics in Hematologic Malignancies

Copyright © 2025 theMednet
All Rights Reserved.